17.14
+0.17(+1.00%)
Currency In USD
| Previous Close | 16.97 |
| Open | 17.13 |
| Day High | 17.8 |
| Day Low | 17.05 |
| 52-Week High | 18.15 |
| 52-Week Low | 8.03 |
| Volume | 1.36M |
| Average Volume | 1.73M |
| Market Cap | 2.06B |
| PE | -23.48 |
| EPS | -0.73 |
| Moving Average 50 Days | 15.63 |
| Moving Average 200 Days | 14.37 |
| Change | 0.17 |
If you invested $1000 in Arcutis Biotherapeutics, Inc. (ARQT) since IPO date, it would be worth $786.24 as of September 18, 2025 at a share price of $17.14. Whereas If you bought $1000 worth of Arcutis Biotherapeutics, Inc. (ARQT) shares 3 years ago, it would be worth $926.99 as of September 18, 2025 at a share price of $17.14.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress
GlobeNewswire Inc.
Yesterday at 8:00 AM GMT
New analysis of ZORYVE foam 0.3% demonstrates reduction in signs and symptoms of seborrheic dermatitis in individuals with diverse skin typesNew data show improved quality of life and decreased impact on families for investigational ZORYVE cream 0.05
Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award
GlobeNewswire Inc.
Sep 16, 2025 1:00 PM GMT
ZORYVE Allure Best of Beauty Product Image Allure Best of Beauty Breakthrough Award Winner ZORYVE (roflumilast) cream 0.15%; ZORYVE (roflumilast) topical foam 0.3%; ZORYVE (roflumilast) cream 0.3% Allure Best of Beauty Award Seal 2025 Allure B
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
GlobeNewswire Inc.
Sep 03, 2025 3:43 PM GMT
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in children as young as 2, offering patients and caregivers an important alternative to topical steroids and vitamin-D analogsZORYVE cream is